Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
With
Palo Alto Veterans Institute for Research
1. Efficacy: Up to 4 weeks of morning bright light exposure will be more efficacious than morning dim light in consolidating nighttime sleep as assessed by actigraphy.
2. Predictors of response: We expect the primary predictor of treatment response will be initial MMSE score. Secondary predictors include baseline sleep/wake and circadian parameters and age.
3. Effectiveness: Bright light treatment will be more effective than dim light in improving quality of life.
4. An understanding of some of the genetic markers of memory and/or sleep problems.
Age
55–100
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Stanford Alzheimer's Disease Core Center member or potential member, with diagnostic criteria met for probable AD, living with caregiver willing to participate in the protocol
Non-institutionalized
Caregivers:
You may not be if
History of manic or bipolar disorder
Prior bright light treatment
Irregular or non-24 hour sleep/wake cycle
Positive result on multi-staged RLS/PLMD
Medical/Ophthalmologic Exclusions
RDI \>20 on overnight EdenTrace® recording
Caregivers:
History of manic or bipolar disorder
Medical/Ophthalmologic Exclusions
Clareo Health | Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease
